The hepatobiliary-specific contrast medium (gadoxetic acid - Primovist®) is primarily used to improve detection and characterization of focal hepatic lesions, such as in chronic liver disease patients with suspected hepatocellular carcinoma. Since the contrast medium is selectively taken up by functioning hepatocytes in the late hepatobiliary phase, it helps to detect typical hepatocellular car...

Hepatobiliary contrast agents currently are essentially gadolinium based agents (Gd-EOB-DTPA and GdBOPTA) with dual ability to perform dynamic contrast enhanced imaging similar to extracellular gadolinium contrast as well as providing hepatobiliary uptake and excretion in later phases. Hepatobiliary uptake and excretion with gadoxetic acid (Gd-EOB-DTPA) is related to OATP and cMOAT and MRP2 rec...

Objectives: We observed the time-course changes of blood flow in non-hypervascular hepatocellular nodules that showed hypointensity in the hepatobiliary phase on Gd-EOB-DTPA-enhanced magnetic resonance imaging (EOB-MRI), and evaluated the relationship between hypervascular change and the status of blood supply in the nodules. Methods: The study included 69 hepatocellular nodules in 33 patients ...

Gadoxetate disodium is a widely used magnetic resonance (MR) contrast agent for liver MR imaging, and it provides both dynamic and hepatobiliary phase images. However, acquiring optimal arterial phase images at liver MR using gadoxetate disodium is more challenging than using conventional extracellular MR contrast agent because of the small volume administered, the gadolinium content of the age...

the purpose of this study was to investigate the potential responses of the cardiovascular system and regional blood flow to hypoxic hypoxia (bb) and to carbon monoxide (co)-induced hypoxia (coh). ten anesthetized cats were studied under two nonnoxic (control: cont) and two hypoxic conditions. four types of radioactive micro spheres were used to measure regional blood flow during cont and two h...

PURPOSE: Hepatobiliary contrast agents add an additional form of image contrast to hepatic magnetic resonance (MR) imaging, allowing differentiation of tumors which have functional hepatic and biliary components from those without. Gd-EOB-DTPA has sufficiently significant elimination via the hepatobiliary pathway to make it a feasible contrast agent in the time allotted to a typical clinical ab...